PRESS RELEASE 10 JULY 2017 Revenues for the 1st half of 2017: sustained activity

(€m)

S1 2017

S1 2016

Δ %

6 months

S1 2017

like-for-like*

Δ %

like-for-like*

Specialty Chemicals

19.0

19.1

- 0.6 %

18.8

- 1.3 %

Food & Retail

23.8

22.5

5.9 %

23.8

5.9 %

Healthcare & Industry

52.8

53.2

- 0.8 %

52.6

- 1.2 %

Luxury & Beauty

99.4

98.9

0.5 %

93.5

- 5.4 %

PSB INDUSTRIES Group**

194.7

193.3

0.7 %

188.4

- 2.6 %

*Like-for-like: assuming constant foreign exchange rates and scope of consolidation, i.e. application of the foreign exchange rates for 2016 to foreign subsidiaries' revenues for 2017 and based on the Group's scope of consolidation in 2016 (so excluding Topline Products for January 2017).

**After elimination of interdivisional billings.

PSB INDUSTRIES has achieved S1 2017 revenues of €194.7 million, an increase of +0.7% compared to the 1st half of 2016 (-

2.6 % like-for-like), including a contribution of Topline (consolidated with effect from 1st February 2016) amounting to €5.6 million for January 2017. As expected, the Group's activity was stronger in the 2nd quarter of 2017 (+0.8% like-for-like), essentially as the result of new product launches and of new business in all our markets.

Specialty Chemicals: The business unit's (BU) activity for S1 was stable with a very slight drop of -0.6%, but strong Q2 growth (+16.7% like-for-like) reflecting sustained technical ceramic and polishing sales which offset the expected fall in the market for traditional lighting products. With its new positioning in highly technical markets, the BU has henceforth adopted a long- term trajectory of higher added value.

Food & Retail: The business unit's revenues increased by +5.9% over the 1st half of 2016, with a very dynamic 2nd quarter (+14%) and a positive baseline effect. The BU both reaped the benefit of the food market's overall S1 growth of 12% and, in parallel, pursued its efforts of innovation and has deployed a new proprietary range, SoPack, for its customers.

Healthcare & Industry: The business unit's activity for S1 was virtually stable at €52.8 million, with a fall of only -0.8% over the 1st half of 2016 (-1.2% like-for-like), despite the temporary reduction of business of a pharmaceutical customer in France and the strategic refocus of the BU's non-healthcare customer/product portfolio. The BU's activities for S1 reaped the benefit of the industrial investment of 2016 in France, Mexico and Poland where the buoyancy of sales sufficed to offset the slower than expected pace of the North American upturn. The BU has continued its policy of development within promising markets such as medical appliances, aeronautics and niche markets and possesses a significant portfolio of projects under consideration.

Luxury & Beauty: The business unit gained +0.5% in S1 2017 with sales of €99.4 million. Assuming constant foreign exchange rates and scope of consolidation (so excluding Topline for January 2017), the fall-back in business compared to S1 2016 amounted to -5.4%. As expected, the 2nd quarter has confirmed the upturn in revenues attributable to the launch of new products (makeup and skincare products for Lancôme, Dior, Gemey Maybelline, Chanel, Yves Saint Laurent etc.) and the billing of moulds, and this has offset the scheduled termination of certain Topline references mainly in the USA. The rhythm of new launches is expected to accelerate during S2 2017. The BU is committed to a strategy of globalisation of its product offering and continues to develop the new eco-system of partnerships designed to enable it to consolidate its position as a Solution Provider for major global customers.

Evolving within markets that are dynamic despite the volatile context of the economy as a whole, and boosted by the success of its tenders of 2016 and early 2017, the Group confirms its expectations of growth for S2 2017 and 2018.

Next date for your diary: publication of results for the 1st half of 2017 on 27 July 2017 after close of the market

PSB INDUSTRIES is an innovative industrial group and market leader for packaging and specialty chemicals.

In 2016 the Group achieved revenue of €377 million, of which more than 60% internationally, with production facilities in

France, the USA, Poland, Japan, China and Mexico.

Euronext Paris - Compartment B - ISIN FR0000060329 - Cac Small, Cac Mid & Small, All-Tradable Indices Full financial results for the company are available at: www.psbindus.com - finance@psbindus.com PSB INDUSTRIES is eligible for French PEA-PME savings accounts

PSB Industries SA published this content on 10 July 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 13 July 2017 08:39:04 UTC.

Original documenthttp://en.psbindus.com/public/resources/block/15/1886_0_59673096c0fbe.pdf

Public permalinkhttp://www.publicnow.com/view/1B94BD033B11B8FC5AEA8F51C7DA504BFC1C094E